healio.com
IBD, several GI cancers join growing list of risks for patients with celiac disease
People with celiac disease may have higher risks for several digestive cancers and for inflammatory bowel diseases (Crohn’s and UC) according to this large French cohort study. Knowing these associations can help patients and clinicians consider appropriate monitoring and specialist care discussions.
Patients with celiac disease, clinicians (gastroenterologists, primary care), and researchers studying cancer risk or autoimmune comorbidities.
What To Know
What to know This Healio news piece reports on a nationwide French cohort study (Jannot et al., Clin Gastroenterol Hepatol) that examined risks for digestive cancers and other immune-mediated conditions in people hospitalized with celiac disease.
The study found higher risks for non-Hodgkin lymphoma and small-bowel cancer, and elevated risks for pancreatic, esophageal, gastric and colonic cancers. It also reported increased odds of Crohn’s disease, ulcerative colitis, microscopic colitis/noninfectious enterocolitis, type 1 diabetes, thyroiditis, rheumatoid arthritis and osteoporosis.
The article summarizes the study design (27,114 hospitalized celiac patients matched 1:1 to controls with ~9 years follow-up) and presents the reported odds ratios for several outcomes without providing individual patient-level details or management recommendations.
If you want the original data or to read study limitations, the Healio item cites the Clinical Gastroenterology and Hepatology publication (Jannot AS, et al.; doi:10.1016/j.cgh.2024.10.028), which is the primary source.
Who should pay attention Patients with celiac disease, clinicians who care for people with celiac disease or IBD, and researchers interested in cancer risk and autoimmune comorbidity. More context This is a summary of an observational, registry-based cohort study reported in a peer-reviewed journal; such studies show associations but cannot prove causation.
The Healio article reports study ORs and outcomes but does not include detailed methods or potential confounders; consult the original Clin Gastroenterol Hepatol paper for full methods and limitations.
Observational cohort data show associations but not causation; the Healio summary reports odds ratios and named outcomes but does not replace reading the original journal article for methods and limitations.
